MX2021012364A - Proceso para fabricar cristales de farmacos con la distribucion de tama?o y la morfologia deseadas. - Google Patents

Proceso para fabricar cristales de farmacos con la distribucion de tama?o y la morfologia deseadas.

Info

Publication number
MX2021012364A
MX2021012364A MX2021012364A MX2021012364A MX2021012364A MX 2021012364 A MX2021012364 A MX 2021012364A MX 2021012364 A MX2021012364 A MX 2021012364A MX 2021012364 A MX2021012364 A MX 2021012364A MX 2021012364 A MX2021012364 A MX 2021012364A
Authority
MX
Mexico
Prior art keywords
morphology
size distribution
desired size
drug crystals
making drug
Prior art date
Application number
MX2021012364A
Other languages
English (en)
Inventor
Troy Loss
Azadeh Goudarzi
Michael Gaines
Gina Stetsko
Amanda Malone
Original Assignee
Eupraxia Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eupraxia Pharmaceuticals Inc filed Critical Eupraxia Pharmaceuticals Inc
Publication of MX2021012364A publication Critical patent/MX2021012364A/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0059—General arrangements of crystallisation plant, e.g. flow sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/54—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/004—Fractional crystallisation; Fractionating or rectifying columns
    • B01D9/0045—Washing of crystals, e.g. in wash columns
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B07—SEPARATING SOLIDS FROM SOLIDS; SORTING
    • B07B—SEPARATING SOLIDS FROM SOLIDS BY SIEVING, SCREENING, SIFTING OR BY USING GAS CURRENTS; SEPARATING BY OTHER DRY METHODS APPLICABLE TO BULK MATERIAL, e.g. LOOSE ARTICLES FIT TO BE HANDLED LIKE BULK MATERIAL
    • B07B13/00—Grading or sorting solid materials by dry methods, not otherwise provided for; Sorting articles otherwise than by indirectly controlled devices
    • B07B13/04—Grading or sorting solid materials by dry methods, not otherwise provided for; Sorting articles otherwise than by indirectly controlled devices according to size
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B33/00—After-treatment of single crystals or homogeneous polycrystalline material with defined structure
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
    • C30B7/02—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions by evaporation of the solvent
    • C30B7/06—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions by evaporation of the solvent using non-aqueous solvents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Glanulating (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Steroid Compounds (AREA)

Abstract

El presente documento incluye un proceso para la formación de cristales de fármacos de distribución de tamaño estrecho y dimensiones y morfología deseadas, el proceso incluye un paso de recristalización seguido de un paso de redimensionamiento.
MX2021012364A 2019-04-10 2020-04-10 Proceso para fabricar cristales de farmacos con la distribucion de tama?o y la morfologia deseadas. MX2021012364A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962832179P 2019-04-10 2019-04-10
PCT/US2020/027797 WO2020210720A1 (en) 2019-04-10 2020-04-10 Process for making drug crystals of desired size distribution and morphology

Publications (1)

Publication Number Publication Date
MX2021012364A true MX2021012364A (es) 2022-01-18

Family

ID=72752032

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021012364A MX2021012364A (es) 2019-04-10 2020-04-10 Proceso para fabricar cristales de farmacos con la distribucion de tama?o y la morfologia deseadas.

Country Status (12)

Country Link
US (1) US20220168665A1 (es)
EP (1) EP3952842A4 (es)
JP (1) JP7547364B2 (es)
KR (1) KR20220025703A (es)
CN (1) CN114040752A (es)
AU (1) AU2020272057A1 (es)
BR (1) BR112021020319A2 (es)
CA (1) CA3136619A1 (es)
IL (1) IL287091A (es)
MX (1) MX2021012364A (es)
SG (1) SG11202111186TA (es)
WO (1) WO2020210720A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024077017A1 (en) 2022-10-04 2024-04-11 Eupraxia Pharmaceuticals Inc. Use of long-acting fluticasone propionate injectable suspensions for treating and preventing inflammations of the gastrointestinal tract

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1329316A (en) * 1970-12-08 1973-09-05 Kerr Mc Gee Chem Corp Process for automatic control of crystal size distribution
DE59105546D1 (de) * 1990-03-20 1995-06-29 Asea Brown Boveri Verfahren zur Erzeugung von längsgerichteten grobkörnigen Stengelkristallen in einem aus einer oxyddispersionsgehärteten Nickelbasis-Superlegierung bestehenden Werkstück.
JP3807086B2 (ja) * 1998-03-23 2006-08-09 味の素株式会社 粒度分布制御晶析法
EP1280604B1 (en) * 2000-05-10 2008-03-19 Jagotec AG Media milling
CN1960708A (zh) * 2003-07-22 2007-05-09 巴克斯特国际公司 低分子量有机分子的小球颗粒及其制备方法和应用
US20060078573A1 (en) * 2004-06-11 2006-04-13 Theodore Randolph Methods of modifying crystal habit
WO2007106768A2 (en) * 2006-03-14 2007-09-20 Merck & Co., Inc. Processes and apparatuses for the production of crystalline organic microparticle compositions by micro-milling and crystallization on micro-seed and their use
CN101757634A (zh) * 2008-11-28 2010-06-30 天津金耀集团有限公司 采用环糊精包合丙酸氟替卡松的鼻用药物组合物
JP2014520848A (ja) * 2011-07-08 2014-08-25 ファイザー・リミテッド １型プロピオン酸フルチカゾンの調製のための方法
EP2976062B1 (en) 2013-03-21 2021-11-03 Eupraxia Pharmaceuticals USA LLC Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
US9802926B2 (en) * 2014-06-20 2017-10-31 Aviragen Therapeutics, Inc. Anhydrous crystalline free base form of 6-{2-[1 -(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzisoxazole
CN108289857A (zh) * 2015-10-27 2018-07-17 优普顺药物公司 局部麻醉药的持续释放制剂

Also Published As

Publication number Publication date
BR112021020319A2 (pt) 2021-12-14
CN114040752A (zh) 2022-02-11
JP2022526649A (ja) 2022-05-25
JP7547364B2 (ja) 2024-09-09
SG11202111186TA (en) 2021-11-29
CA3136619A1 (en) 2020-10-15
US20220168665A1 (en) 2022-06-02
IL287091A (en) 2021-12-01
AU2020272057A1 (en) 2021-11-04
EP3952842A4 (en) 2023-01-11
EP3952842A1 (en) 2022-02-16
KR20220025703A (ko) 2022-03-03
WO2020210720A1 (en) 2020-10-15

Similar Documents

Publication Publication Date Title
AU2020330570A8 (en) Process of making CFTR modulators
WO2018086591A8 (zh) 吡啶胺取代的杂三环化合物、其制法与医药上的用途
EP3784461A4 (en) PROCESS FOR MANUFACTURE OF A CELLULOSIC PRODUCT
EP4219526A3 (en) Method for preparing amg 416
MX2021008985A (es) Procedimiento de fabricacion continuo para la fabricacion de productos biologicos mediante integracion de procedimientos de principio activo y producto terminado.
WO2017171441A3 (ko) 페라이트계 촉매, 이의 제조방법 및 이를 이용한 부타디엔의 제조방법
EP3758500A4 (en) METHOD FOR MANUFACTURING A CHOCOLATE COMPOSITION, CHOCOLATE PRODUCT AND CHOCOLATE COMPOSITION
MX2020009843A (es) Formas cristalinas y metodos de produccion de formas cristalinas de un compuesto.
EP4076003A4 (en) METHOD OF INCREASING THE PRODUCTIVITY OF A NON-RUMINATED ANIMAL
GB2585450B (en) Tablet production
MX2021012364A (es) Proceso para fabricar cristales de farmacos con la distribucion de tama?o y la morfologia deseadas.
EP3967784A4 (en) ALLOY MATERIAL AND MANUFACTURING METHOD THEREOF
EP3859029A4 (en) METAL MASK MATERIAL, ITS PRODUCTION METHOD AND METAL MASK
PH12019501678A1 (en) Potassium channel modulators
MX2017015322A (es) Composicion farmaceutica oral de isotretinoin.
EP4079755A4 (en) METHOD FOR PRODUCING AN ORGANOID
MX2022004209A (es) Formas cristalinas de estado solido de un modulador selectivo de canales de potasio.
MX2022000287A (es) Composición de inhibidor micromolécular de pi4kiiia, método de preparación y uso.
PL3894232T3 (pl) Sposób wytwarzania półproduktu foliowego, półprodukt foliowy oraz sposób wytwarzania produktu
WO2016161988A3 (zh) 一种含有球形硫酸氢氯吡格雷i晶型的药物组合物及其制备方法
EP3730308A4 (en) CLICHÉ MATRIX FOR LITHOGRAPHIC PLATE, AND LITHOGRAPHIC PLATE PRODUCTION PROCESS
MX2020003598A (es) Composicion de material de revestimiento a base de yeso para moldeo y metodo de fabricacion de composicion de material de revestimiento a base de yeso para moldeo.
WO2018144607A8 (en) Apparatus and continuous flow process for production of boronic acid derivative
EP3766494A4 (en) LENALIDOMIDE GASTRIC RETENTION EXTENDED RELEASE TABLET AND METHOD OF PREPARATION
EP4082998A4 (en) PROCESS FOR PRODUCING 1,4-CYCLOHEXANEDIMETHANOL